Michael Berk, MBBCh, MMed(Psych), FC(Psych), PhD

Interpersonal Trauma and Depression Severity in Bipolar Disorder

April 10, 2023

In bipolar disorder patients currently receiving treatment, a history of childhood trauma was associated with more severe depression.

Anna L. Wrobel, Samantha E. Russell, Anuradhi Jayasinghe, et al

Meta-Analysis

N-Acetylcysteine in Depressive Symptoms and Functionality: A Systematic Review and Meta-Analysis

April 27, 2016

Brisa S. Fernandes, Olivia M. Dean, Seetal Dodd, et al

Original Research

Effects of Asenapine in Bipolar I Patients Meeting Proxy Criteria for Moderate-to-Severe Mixed Major Depressive Episodes: A Post Hoc Analysis

June 24, 2015

Michael Berk, John W. G. Tiller, Jun Zhao, et al

Meta-Analysis

Nocebo Effects in the Treatment of Major Depression: Results From an Individual Study Participant-Level Meta-Analysis of the Placebo Arm of Duloxetine Clinical Trials

June 24, 2015

Seetal Dodd, Alexander Schacht, Katarina Kelin, et al

Letter to the Editor

Effects of N-Acetyl Cysteine on Suicidal Ideation in Bipolar Depression

May 27, 2015

Astrid Waterdrinker, Michael Berk, Kamalesh Venugopal, et al

Original Research

Efficiency of N-Acetylcysteine in MDD

June 27, 2014

Read about the Efficacy of N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial.

Michael Berk, Olivia M. Dean, Sue M. Cotton, et al

Original Research

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

March 15, 2013

Jonathan P. Stange, Louisa G. Sylvia, Pedro Vieira da Silva Magalhães, et al

Original Research

The Use of Statins After a Cardiac Intervention Is Associated With Reduced Risk of Subsequent Depression: Proof of Concept for the Inflammatory and Oxidative Hypotheses of Depression?

December 14, 2010

Lesley Stafford, Michael Berk

Original Research

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

September 21, 2010

Michael Berk, Ahmed Munib, Olivia Dean, et al

Original Research

Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine

October 15, 2009

David de Lucena, Brisa SimÃµes Fernandes, Michael Berk, et al

Original Research

Olanzapine/Fluoxetine Combination for the Treatment of Mixed Depression in Bipolar I Disorder: A Post Hoc Analysis

October 15, 2009

Franco Benazzi, Michael Berk, Mark A. Frye, et al

Original Research

Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions

June 30, 2009

Patrick D. McGorry, Barnaby Nelson, G. Paul Amminger, et al

Michael Berk, MBBCh, MMed(Psych), FC(Psych), PhD

Interpersonal Trauma and Depression Severity in Bipolar Disorder

N-Acetylcysteine in Depressive Symptoms and Functionality: A Systematic Review and Meta-Analysis

Effects of Asenapine in Bipolar I Patients Meeting Proxy Criteria for Moderate-to-Severe Mixed Major Depressive Episodes: A Post Hoc Analysis

Nocebo Effects in the Treatment of Major Depression: Results From an Individual Study Participant-Level Meta-Analysis of the Placebo Arm of Duloxetine Clinical Trials

Effects of N-Acetyl Cysteine on Suicidal Ideation in Bipolar Depression

Efficiency of N-Acetylcysteine in MDD

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

The Use of Statins After a Cardiac Intervention Is Associated With Reduced Risk of Subsequent Depression: Proof of Concept for the Inflammatory and Oxidative Hypotheses of Depression?

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine

Olanzapine/Fluoxetine Combination for the Treatment of Mixed Depression in Bipolar I Disorder: A Post Hoc Analysis

Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions

ELSEWHERE:

FOLLOW US:

Michael Berk, MBBCh, MMed(Psych), FC(Psych), PhD

Interpersonal Trauma and Depression Severity in Bipolar Disorder

N-Acetylcysteine in Depressive Symptoms and Functionality: A Systematic Review and Meta-Analysis

Effects of Asenapine in Bipolar I Patients Meeting Proxy Criteria for Moderate-to-Severe Mixed Major Depressive Episodes: A Post Hoc Analysis

Nocebo Effects in the Treatment of Major Depression: Results From an Individual Study Participant-Level Meta-Analysis of the Placebo Arm of Duloxetine Clinical Trials

Effects of N-Acetyl Cysteine on Suicidal Ideation in Bipolar Depression

Efficiency of N-Acetylcysteine in MDD

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

The Use of Statins After a Cardiac Intervention Is Associated With Reduced Risk of Subsequent Depression: Proof of Concept for the Inflammatory and Oxidative Hypotheses of Depression?

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine

Olanzapine/Fluoxetine Combination for the Treatment of Mixed Depression in Bipolar I Disorder: A Post Hoc Analysis

Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles